Globally, over 400 Million suffer from asthma yet the classic “blue puffer” has not seen innovation in nearly 70 years. PALM is a patient-centred solution leveraging innovative microfluidic technology to breathe new life into inhaled therapy. Together with collaborators across Monash University, PALM reimagines inhaled therapy seamless through a tailored easy-to-use and data-driven experience.
Winner of the Good Design Award - Best in Class in the Design Research category (2023)